Company Filing History:
Years Active: 2025
Title: Liwen Mao - Innovator in Renal Fibrosis Treatment
Introduction
Liwen Mao is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of drug preparation, particularly in the treatment of renal fibrosis. His innovative work has the potential to impact clinical practices and improve patient outcomes.
Latest Patents
Liwen Mao holds a patent titled "Use of chidamide in preparing drug for treating renal fibrosis." This patent focuses on the application of chidamide in drug formulation, demonstrating its effectiveness in significantly improving the fibrosis of TGF-β stimulated HK2 cells. The research indicates that chidamide can notably enhance renal fibrosis in UUO mice and ameliorate the condition through the PI3K/Akt signaling pathway. This discovery presents wide clinical application prospects.
Career Highlights
Liwen Mao is affiliated with Soochow University, where he conducts research and develops innovative solutions in the medical field. His work has garnered attention for its potential to transform treatment approaches for renal fibrosis.
Collaborations
Liwen Mao collaborates with esteemed colleagues, including Zhanhong Hu and Yumei Liu, who contribute to his research endeavors. Their combined expertise enhances the quality and impact of their work.
Conclusion
Liwen Mao's contributions to the field of renal fibrosis treatment through his innovative use of chidamide highlight the importance of research and development in medicine. His work not only advances scientific knowledge but also holds promise for improving patient care in the future.